REQUEST FOR RESEARCH PROPOSALS ISSUED

NETRF has announced a new round of scientific and clinical research grants, aimed at advancing the treatment of and the search for cures to neuroendocrine tumors (NETs). (MORE)

Caring and Sharing

Reporting on Progress

WHAT DOES IT TAKE TO FIND A CURE?

It takes your support, our leadership, and the world’s best scientists. By working together, we can change the outlook for those facing a neuroendocrine cancer diagnosis. (MORE)

Research

ASCO ROUNDUP

Every June, cancer specialists present their latest findings to their peers at the annual meeting of the American Society of Clinical Oncology (ASCO). See what caught our attention. (MORE)

Meet the researchers...

2017 PETERSEN INVESTIGATOR

Laura Banaszynski, Ph.D., has always been passionate about science. After training as a chemical biologist, her innate curiosity pushed her to explore the mysteries of cells as a basic researcher. And the protein that most fascinates her contributes to NETs. (MORE)

Education

OPTIMIZING SURVIVORSHIP

8 Steps to Better Balance

The experience of NETs profoundly changes people’s lives. Fatigue, isolation, worry, and bothersome physical side effects can disrupt daily activities. Here are some simple steps to maintain optimal health and balance during and after cancer care. (MORE)

Awards and Announcements

OUTSTANDING ACHIEVEMENT

A NETRF-funded researcher earned the highest honor from the American Society of Clinical Oncology (ASCO) as part of its Annual Meeting in Chicago. Carl June, MD, University of Pennsylvania, received the David A. Karnofsky Memorial Award for outstanding contributions to cancer research, diagnosis, and treatment. (MORE)

NETRF WELCOMES

NETRF has announced the appointment of Donna Dubuc as Director of Communications, a pivotal post in expanding awareness of the need for research in improving care for neuroendocrine cancers. Donna is a veteran health communications leader with a specialized interest in cancer. (MORE)

We are pleased to announce that this eUpdate
is sponsored by Novartis Pharmaceutical Corporation.

DONATE

The mission of the Neuroendocrine Tumor Research Foundation is to fund research to discover cures and more effective treatments for carcinoid, pancreatic, and related neuroendocrine cancers.

NETRF is a 501(c)(3) organization. All contributions are tax-deductible to the extent allowed by law. To learn more,
view our Audited Financial Statements and IRS Form 990.

Manage your preferences | Opt out using TrueRemove™
Got this as a forward? Sign up to receive our future emails.
View this email online.

321 Columbus Avenue, Suite 5R
Boston, MA | 02116 US

This email was sent to .
To continue receiving our emails, add us to your address book.